Suppr超能文献

阿维A在雄性和雌性斯普拉格-道利大鼠中的肝酶诱导潜力。

Hepatic enzyme induction potential of acitretin in male and female Sprague-Dawley rats.

作者信息

Small D S, McNamara P J

机构信息

Division of Pharmacology and Experimental Therapeutics, College of Pharmacy, University of Kentucky, Lexington 40536-0082.

出版信息

J Pharm Sci. 1994 May;83(5):662-7. doi: 10.1002/jps.2600830514.

Abstract

Certain retinoids have been shown in rats and mice to induce the hepatic cytochrome P-450 enzyme system, and evidence from our laboratory suggested that acitretin, the active primary metabolite of etretinate (a retinoid used in the treatment of psoriasis) may induce its own metabolism. To test this hypothesis, male and female Sprague-Dawley rats were orally pretreated with acitretin for 18 days (10 mg/kg/day) and intravenously dosed with acitretin on day 20 (0.8-0.9 mg/kg). Serial blood samples were taken through 24 h, after which the hepatic microsomal proteins were harvested. Plasma concentrations of acitretin and its main metabolite isoacitretin were determined by HPLC, and total hepatic cytochrome P-450 concentrations and activities were determined using standard methods. Systemic clearance (17.4 +/- 2.5 and 12.1 +/- 1.6 mL/min per kg in control males and females, respectively), volume of distribution at steady state (Vss = 1568 +/- 353 and 1589 +/- 488 mL in control males and females, respectively), and mean residence time (MRT = 1.50 +/- 0.23 and 2.22 +/- 0.70 h in control males and females, respectively) were unchanged by acitretin pretreatment. Systemic clearance was 44% higher in control males than females. Concentrations of total microsomal protein (13.8 +/- 1.6 and 8.4 +/- 1.2 mg/g of liver in control males and females, respectively) and total P-450 (0.433 +/- 0.041 and 0.425 +/- 0.104 nmol/mg microsomal protein in control males and females, respectively) were also unchanged by acitretin pretreatment, as were microsomal levels of methoxy-, ethoxy-, pentoxy-, and (benzyloxy)resorufin O-dealkylation (MROD, EROD, PROD, and BROD, respectively) (control males and females, respectively, expressed as pmol of resorufin formed/min per mg of microsomal protein: MROD = 37.7 +/- 4.5 and 30.6 +/- 4.2; EROD 276 +/- 40 and 208 +/- 59; PROD = 15.2 +/- 4.5 and 5.8 +/- 1.2; and BROD 93.7 +/- 24.4 and 15.5 +/- 3.9).(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

在大鼠和小鼠中已表明,某些类视黄醇可诱导肝细胞色素P-450酶系统,并且我们实验室的证据表明,阿维A(依曲替酯(一种用于治疗银屑病的类视黄醇)的活性主要代谢产物)可能诱导自身代谢。为验证这一假设,对雄性和雌性Sprague-Dawley大鼠口服阿维A预处理18天(10毫克/千克/天),并在第20天静脉注射阿维A(0.8 - 0.9毫克/千克)。在24小时内采集系列血样,之后收集肝微粒体蛋白。通过高效液相色谱法测定阿维A及其主要代谢产物异维A酸的血浆浓度,并使用标准方法测定总肝细胞色素P-450浓度和活性。阿维A预处理后,全身清除率(对照雄性和雌性分别为17.4±2.5和12.1±1.6毫升/分钟/千克)、稳态分布容积(对照雄性和雌性分别为Vss = 1568±353和1589±488毫升)以及平均驻留时间(对照雄性和雌性分别为MRT = 1.50±0.23和2.22±0.70小时)均未改变。对照雄性的全身清除率比雌性高44%。阿维A预处理后,总微粒体蛋白浓度(对照雄性和雌性分别为13.8±1.6和8.4±1.2毫克/克肝脏)和总P-450(对照雄性和雌性分别为0.433±0.041和0.425±0.104纳摩尔/毫克微粒体蛋白)也未改变,甲氧基、乙氧基、戊氧基和(苄氧基)试卤灵O-脱烷基作用(分别为MROD、EROD、PROD和BROD)的微粒体水平同样未改变(对照雄性和雌性分别表示为每分钟每毫克微粒体蛋白形成的试卤灵皮摩尔数:MROD = 37.7±4.5和30.6±4.2;EROD 276±40和208±59;PROD = 15.2±4.5和5.8±1.2;BROD 93.7±24.4和15.5±3.9)。(摘要截短于250字)

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验